Protein Tyrosine Phosphatases, TC-PTP, SHP1, and SHP2, Cooperate in Rapid Dephosphorylation of Stat3 in Keratinocytes Following UVB Irradiation

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Kim, Dae Joon ^a,c   Tremblay, Michel L ^b   DiGiovanni, John ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MYC PROTEIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; PROTEIN BCL XL; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; SMALL INTERFERING RNA; STAT3 PROTEIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE; PTPN11 PROTEIN, MOUSE; PTPN2 PROTEIN, MOUSE; PTPN6 PROTEIN, MOUSE; STAT3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; EPIDERMIS; FEMALE; GENE SILENCING; GENE TARGETING; GENE TRANSLOCATION; GENETIC TRANSFECTION; KERATINOCYTE; MOUSE; NEWBORN; NONHUMAN; PROTEIN DEPHOSPHORYLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RADIATION EXPOSURE; RNA INTERFERENCE; ULTRAVIOLET B RADIATION; ANIMAL; APOPTOSIS; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; CELLS, CULTURED; KERATINOCYTES; MICE; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; ULTRAVIOLET RAYS;

EID: 77956398497     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010290     Document Type: Article

References (53)

1. Bowman T, Garcia R, Turkson J, Jove R (2000) STATs in oncogenesis. Oncogene 19: 2474-2488.
2. Bromberg J (2002) Stat proteins and oncogenesis. J Clin Invest 109: 1139-1142.
3. Levy DE, Darnell JE, Jr. (2002) Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3: 651-662.
4. Levy DE, Lee CK (2002) What does Stat3 do? J Clin Invest 109: 1143-1148.
5. Darnell JE, Jr. (1997) STATs and gene regulation. Science 277: 1630-1635.
6. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, et al. (1999) Stat3 as an oncogene. Cell 98: 295-303.
7. Turkson J, Jove R (2000) STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19: 6613-6626.
8. Kim DJ, Chan KS, Sano S, Digiovanni J (2007) Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis. Mol Carcinog 46: 725-731.
9. Sano S, Chan KS, Digiovanni J (2007) Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases. J Dermatol Sci.
10. Chan KS, Sano S, Kiguchi K, Anders J, Komazawa N, et al. (2004) Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest 114: 720-728.
11. Kataoka K, Kim DJ, Carbajal S, Clifford JL, DiGiovanni J (2008) Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis. Carcinogenesis 29: 1108-1114.
12. Kim DJ, Kataoka K, Rao D, Kiguchi K, Cotsarelis G, et al. (2009) Targeted disruption of stat3 reveals a major role for follicular stem cells in skin tumor initiation. Cancer Res 69: 7587-7594.
13. Chan KS, Sano S, Kataoka K, Abel E, Carbajal S, et al. (2008) Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis. Oncogene 27: 1087-1094.
14. Sano S, Chan KS, Kira M, Kataoka K, Takagi S, et al. (2005) Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Cancer Res 65: 5720-5729.
15. Kim DJ, Angel JM, Sano S, DiGiovanni J (2009) Constitutive activation and targeted disruption of signal transducer and activator of transcription 3 (Stat3) in mouse epidermis reveal its critical role in UVB-induced skin carcinogenesis. Oncogene 28: 950-960.
16. You-Ten KE, Muise ES, Itie A, Michaliszyn E, Wagner J, et al. (1997) Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J Exp Med 186: 683-693.
17. Sano S, Itami S, Takeda K, Tarutani M, Yamaguchi Y, et al. (1999) Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. Embo J 18: 4657-4668.
18. Dlugosz AA, Glick AB, Tennenbaum T, Weinberg WC, Yuspa SH (1995) Isolation and utilization of epidermal keratinocytes for oncogene research. Methods Enzymol 254: 3-20.
19. Klann RC, Fitzgerald DJ, Piccoli C, Slaga TJ, Yamasaki H (1989) Gapjunctional intercellular communication in epidermal cell lines from selected stages of SENCAR mouse skin carcinogenesis. Cancer Res 49: 699-705.
20. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, et al. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771.
21. Ibarra-Sanchez MJ, Wagner J, Ong MT, Lampron C, Tremblay ML (2001) Murine embryonic fibroblasts lacking TC-PTP display delayed G1 phase through defective NF-kappaB activation. Oncogene 20: 4728-4739.
22. Flint AJ, Tiganis T, Barford D, Tonks NK (1997) Development of "substratetrapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci USA 94: 1680-1685.
23. Xie L, Zhang YL, Zhang ZY (2002) Design and characterization of an improved protein tyrosine phosphatase substrate-trapping mutant. Biochemistry 41: 4032-4039.
24. Sekine Y, Tsuji S, Ikeda O, Sato N, Aoki N, et al. (2006) Regulation of STAT3- mediated signaling by LMW-DSP2. Oncogene 25: 5801-5806.
25. Shields BJ, Hauser C, Bukczynska PE, Court NW, Tiganis T (2008) DNA replication stalling attenuates tyrosine kinase signaling to suppress S phase progression. Cancer Cell 14: 166-179.
26. Wang S, Raven JF, Baltzis D, Kazemi S, Brunet DV, et al. (2006) The catalytic activity of the eukaryotic initiation factor-2alpha kinase PKR is required to negatively regulate Stat1 and Stat3 via activation of the T-cell protein-tyrosine phosphatase. J Biol Chem 281: 9439-9449.
27. Yamamoto T, Sekine Y, Kashima K, Kubota A, Sato N, et al. (2002) The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin- 6-mediated signaling pathway through STAT3 dephosphorylation. Biochem Biophys Res Commun 297: 811-817.
28. Zhang X, Guo A, Yu J, Possemato A, Chen Y, et al. (2007) Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T. Proc Natl Acad Sci USA 104: 4060-4064.
29. Kunnumakkara AB, Nair AS, Sung B, Pandey MK, Aggarwal BB (2009) Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1. Mol Cancer Res 7: 118-128.
30. Pandey MK, Sung B, Ahn KS, Aggarwal BB (2009) Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1. Mol Pharmacol 75: 525-533.
31. Ke Y, Zhang EE, Hagihara K, Wu D, Pang Y, et al. (2007) Deletion of Shp2 in the brain leads to defective proliferation and differentiation in neural stem cells and early postnatal lethality. Mol Cell Biol 27: 6706-6717.
32. Aoki N, Matsuda T (2002) A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. Mol Endocrinol 16: 58-69.
33. ten Hoeve J, de Jesus Ibarra-Sanchez M, Fu Y, Zhu W, Tremblay M, et al. (2002) Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol 22: 5662-5668.
34. Simoncic PD, Lee-Loy A, Barber DL, Tremblay ML, McGlade CJ (2002) The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. Curr Biol 12: 446-453.
35. Mattila E, Pellinen T, Nevo J, Vuoriluoto K, Arjonen A, et al. (2005) Negative regulation of EGFR signalling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP. Nat Cell Biol 7: 78-85.
36. Bourdeau A, Dube N, Tremblay ML (2005) Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. Curr Opin Cell Biol 17: 203-209.
37. Mosinger B, Jr., Tillmann U, Westphal H, Tremblay ML (1992) Cloning and characterization of a mouse cDNA encoding a cytoplasmic protein-tyrosinephosphatase. Proc Natl Acad Sci USA 89: 499-503.
38. Lorenzen JA, Dadabay CY, Fischer EH (1995) COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus. J Cell Biol 131: 631-643.
39. Tillmann U, Wagner J, Boerboom D, Westphal H, Tremblay ML (1994) Nuclear localization and cell cycle regulation of a murine protein tyrosine phosphatase. Mol Cell Biol 14: 3030-3040.
40. Lam MH, Michell BJ, Fodero-Tavoletti MT, Kemp BE, Tonks NK, et al. (2001) Cellular stress regulates the nucleocytoplasmic distribution of the proteintyrosine phosphatase TCPTP. J Biol Chem 276: 37700-37707.
41. Chan KS, Carbajal S, Kiguchi K, Clifford J, Sano S, et al. (2004) Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res 64: 2382-2389.
42. Xu Y, Voorhees JJ, Fisher GJ (2006) Epidermal growth factor receptor is a critical mediator of ultraviolet B irradiation-induced signal transduction in immortalized human keratinocyte HaCaT cells. Am J Pathol 169: 823-830.
43. Peus D, Vasa RA, Meves A, Beyerle A, Pittelkow MR (2000) UVB-induced epidermal growth factor receptor phosphorylation is critical for downstream signaling and keratinocyte survival. Photochem Photobiol 72: 135-140.
44. Zhang J, Tsaprailis G, Bowden GT (2008) Nucleolin stabilizes Bcl-X L messenger RNA in response to UVA irradiation. Cancer Res 68: 1046-1054.
45. Stoker AW (2005) Protein tyrosine phosphatases and signalling. J Endocrinol 185: 19-33.
46. Tonks NK, Neel BG (2001) Combinatorial control of the specificity of protein tyrosine phosphatases. Curr Opin Cell Biol 13: 182-195.
47. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, et al. (2004) Protein tyrosine phosphatases in the human genome. Cell 117: 699-711.
48. Tonks NK (2006) Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 7: 833-846.
49. Tiganis T, Bennett AM (2007) Protein tyrosine phosphatase function: the substrate perspective. Biochem J 402: 1-15.
50. Haj FG, Verveer PJ, Squire A, Neel BG, Bastiaens PI (2002) Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum. Science 295: 1708-1711.
51. Tiganis T, Bennett AM, Ravichandran KS, Tonks NK (1998) Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase. Mol Cell Biol 18: 1622-1634.
52. TWTCC (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
53. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, et al. (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39: 857-864.